CLINICAL_TRIALS
trial_result
· 2023-06-07
Clinical Trial Update: Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) [Phase 3]
Summary
Phase 3 trial evaluating bezlotoxumab vs placebo in children with Clostridium difficile infection has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Clostridium Difficile Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-06-07